Chief Executive Officer
Jeff Kindler joined Centrexion Therapeutics as the chief executive officer in 2013. He has more than three decades of business experience and has held leadership positions at some of the world’s most recognized companies. Mr. Kindler is executive chairman of vTv Therapeutics and serves on the board of directors of PPD, Perrigo Company PLC, Intrexon Corp. and SIGA Technologies Inc. He also is venture partner at Lux Capital, managing director at Starboard Capital and global chair for the GLG Institute.
Prior to joining Centrexion, Mr. Kindler was the chairman and chief executive officer of Pfizer. As CEO, he led Pfizer’s $68 billion merger and acquisition of Wyeth, diversified its product portfolio, improved its research and development pipeline, and reshaped the company’s commercial, innovation and leadership models to drive growth and cultural change.
Earlier in his career, Mr. Kindler served as the executive vice president and general counsel for McDonald’s Corp. and was the vice president of litigation and legal policy for the General Electric Co. Prior to GE, he practiced civil and criminal litigation as a partner of William & Connolly.
Mr. Kindler holds a B.A. from Tufts University and a J.D. from Harvard University.